NCT00188942View on ClinicalTrials.gov

A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Major Depressive Disorder
Interventions
DRUG

Fluoxetine+Olanzapine

DRUG

Olanzapine

PROCEDURE

Functional Magnetic Resonance Imaging

Trial Locations (2)

M5G2C4

University Health Network - Toronto General Division, Toronto

M5T2S8

University Health Network - Toronto Western Division, Toronto

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University Health Network, Toronto

OTHER

NCT00188942 - A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder | Biotech Hunter | Biotech Hunter